Nobody wanted to die. The life extension project raised millions with names of famous scientists and promises of ground-breaking research. Trustees earmarked the bulk of the money as a prize to the first researcher who solved the telomerase enzyme problem.
On the morning of January 2, 2020, two independent groups announced successful telomerase enhancement formulas. One was from Atlanta, and the other one from Singapore. The group that proved it was the first to record the formula would get $50 million to continue its research. Peer-reviewed publication was not relevant as both completed it at the same time. The only . . . [more] “The Need for Blockchain Evidence Legislation”